Arakawa A

No ORCID on file · 5 papers in corpus
2020
Cancer science ·doi:10.1111/cas.14340

Interim results from the two-cohort, phase 2 KEYNOTE-100 study (NCT02674061) of 376 patients with previously treated advanced recurrent ovarian cancer (ROC) showed that pembrolizumab monotherapy was associated with an objective response rat…

2017
Scientific reports ·doi:10.1038/s41598-017-14418-5

For endometrial cancer patients, lymphadenectomy is recommended to exclude rarely metastasized cancer cells. This procedure is performed even in patients with low risk of recurrence despite the risk of complications such as lymphedema. A me…

article 2012
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2012.01845.x

AIM: The rate of oocyte decline follows a biphasic pattern, characterized by acceleration between 32 and 38 years old. Ovarian reserve is also affected by external factors, including ovarian disease and iatrogenic damage. The aim of this st…

article 2010
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2010.04.011

Study objectiveTo assess the pathogenesis of catamenial pneumothorax associated with endometriosis from a gynecologic perspective.DesignRetrospective study (Canadian Task Force classification II-2).SettingUniversity hospital.PatientsEleven …

article 2010
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2010.08.696

Study objectiveTo determine how intestinal endometriosis spreads, and, thus, to improve outcomes of curative surgery.DesignDescriptive study (Canadian Task Force classification II-2).SettingUniversity hospital.PatientsTen patients who under…